Two patients developed progressive pulmonary fibrosis years after surviving severe COVID-19 pneumonia, a case series published Friday shows.
Fibrotic lung disease worsened in both cases despite initial stability or improvement, eventually meeting criteria for progressive pulmonary fibrosis and prompting antifibrotic therapy and lung transplant referral, Cureus reported.
The first patient, a 57-year-old man, contracted severe COVID-19 in April 2020 and never fully recovered, requiring long-term oxygen. After years of radiological stability, a new pneumonia in March 2025 triggered progressive restrictive lung disease with extensive fibrotic abnormalities on high-resolution CT.
The second patient, a 64-year-old man, had severe COVID-19 pneumonia in 2021. Initial corticosteroid treatment led to substantial radiological improvement and stability, but in 2025 new subpleural honeycombing appeared alongside significant physiological decline.
In both patients, the absence of conclusive histopathological findings limited diagnostic certainty. However, radiological and clinical progression — including declines in forced vital capacity and diffusing capacity for carbon monoxide, plus new honeycombing on HRCT — met criteria for progressive pulmonary fibrosis. Antifibrotic medication nintedanib was initiated and both patients were referred for lung transplant evaluation.
The authors recommend continued evaluation with lung function testing and serial HRCT because of the unpredictable disease course. For patients who progress despite medical therapy, early referral for lung transplant evaluation is advised.
Cureus began as PeerEMed in 2009 and took its current name in December 2012. Founding editors-in-chief are John R. Adler of Stanford University and Alexander Muacevic of LMU Munich. The journal uses pre-publication peer review followed by an optional post-publication SIQ score, and joined the Springer Nature group in December 2022.
The findings appear alongside a November 2026 PubMed-indexed editorial titled “Time is lung?” “Time is lung? Quantitative CT and earlier detection of progressive pulmonary fibrosis” is a study from the Centre for Lung Health at Vancouver General Hospital and the University of British Columbia.
Earlier coverage: Fatal Gastric Perforation by Ingested Fish Bone With Hepatic Abscess and Peritonitis: Case Report